PHILIP J MEASE, MD
Osteopathic Medicine at Madison St, Seattle, WA
License number
Washington MD00016710
Category
Osteopathic Medicine
Type
Rheumatology
Address
Address
1101 Madison St STE 1000, Seattle, WA 98104
Phone
(206) 386-2001
(206) 386-2083 (Fax)
(206) 386-2083 (Fax)
Personal information
See more information about PHILIP J MEASE at radaris.comName
Address
Phone
1126 Federal Ave E, Seattle, WA 98102
1560 115Th St, Seattle, WA 98133
1101 Madison St, Seattle, WA 98104
515 Minor Ave, Seattle, WA 98104
515 Minor Ave, Seattle, WA 98104
Professional information
Dr. Philip J Mease, Seattle WA - MD (Doctor of Medicine)
Specialties:
Rheumatology
Address:
Seattle Rheumatology Associates
1101 Madison St SUITE 1000, Seattle 98104
(206) 386-2000 (Phone)
1101 Madison St SUITE 1000, Seattle 98104
(206) 386-2000 (Phone)
Procedures:
Joint Drainage, Steroid Injections, Viscosupplementation With Hyaluronate
Conditions:
Arthritis, Behçet's Disease, Bursitis, Chronic Neck Pain, De Quervain's Disease, Degenerative Disc Disease, Enthesopathy of Hip (incl. Trochanteric Bursitis), Fibromyalgia, Gout, Lateral & Medial Epicondylitis (Tennis & Golf Elbow), Low Back Pain, Osteoarthritis, Osteoarthritis of Hand or Wrist, Osteoarthritis of Hip, Osteoarthritis of Knee, Osteoarthritis of Spine, Osteopenia, Osteoporosis, Patellofemoral Pain Syndrome or Knee Pain, Polymyalgia Rheumatica (PMR), Raynaud's Disease, Rheumatoid Arthritis, Sjögren's Syndrome, Spondylitis, Systemic Lupus Erythematosus (SLE), Systemic Sclerosis, Vasculitis
Certifications:
Internal Medicine, 1980, Rheumatology, 1982
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
Seattle Rheumatology Associates
1101 Madison St SUITE 1000, Seattle 98104
Northwest Hospital & Medical Center
1550 North 115Th St, Seattle 98133
Swedish Medical Center
501 East Hampden Ave, Englewood 80113
1101 Madison St SUITE 1000, Seattle 98104
Northwest Hospital & Medical Center
1550 North 115Th St, Seattle 98133
Swedish Medical Center
501 East Hampden Ave, Englewood 80113
Education:
Medical School
Stanford University School Of Medicine
Graduated: 1977
University Of Washington
Graduated: 1978
Graduated: 1981
Graduated: 1982
Stanford University School Of Medicine
Graduated: 1977
University Of Washington
Graduated: 1978
Graduated: 1981
Graduated: 1982
Philip J Mease, Seattle WA
Specialties:
Rheumatologist
Address:
1101 Madison St, Seattle, WA 98104
Education:
Stanford University, School of Medicine - Doctor of Medicine
University of Washington Medical Center - Fellowship - Rheumatology (Internal Medicine)
University of Washington Medical Center - Residency - Internal Medicine
University of Washington Medical Center - Fellowship - Rheumatology (Internal Medicine)
University of Washington Medical Center - Residency - Internal Medicine
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine, American Board of Internal Medicine Sub-certificate in Rheumatology (Internal Medicine)
Md At Seattle Rheumatology Associates
Position:
MD at Seattle Rheumatology Associates
Location:
Greater Seattle Area
Industry:
Medical Practice
Work:
Seattle Rheumatology Associates
-
MD
Education:
Stanford University 1969 - 1977
Compositions And Methods For Treating Cardiovascular Conditions
US Patent:
2002005, May 9, 2002
Filed:
Mar 21, 2001
Appl. No.:
09/814394
Inventors:
Barry Bockow - Seattle WA, US
Marc Erlitz - Kirkland WA, US
Philip Mease - Seattle WA, US
Marc Erlitz - Kirkland WA, US
Philip Mease - Seattle WA, US
International Classification:
A61K031/202
US Classification:
514/560000
Abstract:
There is disclosed compositions and methods for treating or preventing cardiovascular conditions by intravascular administration of an omega fatty acid to a patient in need thereof. The omega fatty acid is intravascularly administered preferably in close proximity to the treatment site. Cardiovascular conditions which may be treated or prevented according to this invention include coronary artery disease, myocardial infarction, cerebrovascular disease, stroke, peripheral vascular disease, and atherosclerosis or thrombosis of arteries or veins supplying any organ system. Thrombosis or restenosis occurring in grafts, stents, and in areas of diagnostic or therapeutic intervention such as angioplasty or diagnostic radiology sites can also be treated or prevented.
Methods For Treating Neurotransmitter-Mediated Pain Syndromes By Topically Administering An Omega Fatty Acid
US Patent:
6201022, Mar 13, 2001
Filed:
Mar 27, 1997
Appl. No.:
8/824931
Inventors:
Philip J. Mease - Seattle WA
Barry I. Bockow - Seattle WA
Marc D. Erlitz - Kirkland WA
Barry I. Bockow - Seattle WA
Marc D. Erlitz - Kirkland WA
Assignee:
MyoRx, Inc. - Seattle WA
International Classification:
A61K 3120, A61K 3160, A61K 3161
US Classification:
514560
Abstract:
Methods are disclosed for treating neurotransmitter-mediated pain syndromes such as fibromyalgia. Such methods include topically administering an effective amount of a composition containing an omega fatty acid in combination with a carrier or diluent. The composition may also contain a cyclo-oxygenase inhibitor and other optional components, such as vitamins A, E and/or C.
Uses And Compositions For Treatment Of Rheumatoid Arthritis
US Patent:
2008016, Jul 10, 2008
Filed:
Apr 10, 2007
Appl. No.:
11/786442
Inventors:
Hartmut Kupper - Mutterstadt, DE
Jeffrey D. Kent - Deerfield IL, US
Mary A. Cifaldi - Gurnee IL, US
John L. Perez - Doylestown PA, US
Gerd R. Burmester - Berlin, DE
Philip Mease - Seattle WA, US
Daniel J. Lovell - Cincinnati OH, US
Edward Keystone - Toronto, CA
Arthur Kavanaugh - San Diego CA, US
Jeffrey D. Kent - Deerfield IL, US
Mary A. Cifaldi - Gurnee IL, US
John L. Perez - Doylestown PA, US
Gerd R. Burmester - Berlin, DE
Philip Mease - Seattle WA, US
Daniel J. Lovell - Cincinnati OH, US
Edward Keystone - Toronto, CA
Arthur Kavanaugh - San Diego CA, US
International Classification:
A61K 39/395, G01N 33/68, A61K 39/09, A61K 39/145, A61P 37/00, A61P 19/02
US Classification:
4241361, 4241581, 436 86, 514 12, 4241331, 4241421, 4242441, 4242091
Abstract:
The invention provides methods, uses and compositions for the treatment of rheumatoid arthritis. The invention describes methods and uses for treating rheumatoid arthritis wherein a TNFα inhibitor, such as a human TNFα antibody, or antigen-binding portion thereof. Also described are methods for determining the efficacy of a TNFα inhibitor for treatment of rheumatoid arthritis in a subject.